XML 40 R30.htm IDEA: XBRL DOCUMENT v3.5.0.2
Related Parties
6 Months Ended
Jun. 30, 2016
Related Party Transactions [Abstract]  
Related Party Disclosure

22.       Related Parties

ArmaGen, Inc. (“ArmaGen”) is a related party as the Company owns 21% of ArmaGen common stock and the parties have a worldwide licensing and collaboration agreement to develop and commercialize AGT-182. For the three and six months ended June 30, 2016, Shire recorded R&D costs arising from the licensing and collaboration arrangement of $1.2 million and $1.7 million, respectively (2015: $5.5 million and $5.9 million, respectively), of which $0.3 million was accrued and unpaid as of June 30, 2016 (2015: $5.4 million).